Target intelligence / Profile preview

Nuclear DNA (DNA) (DNA)

Target
DNA
Molecular classification
Nucleic acid
01

Overview

Nuclear DNA is the primary repository of genetic information in eukaryotic cells and serves as the fundamental molecular target for platinum-based chemotherapeutic agents like oxaliplatin (StatPearls, NBK542163). Oxaliplatin exerts its anti-tumor activity by forming covalent bonds with DNA bases, specifically creating 1,2-intrastrand crosslinks between adjacent guanine residues (PubChem, CID 43805). These platinum-DNA adducts cause significant structural distortion of the double helix, which physically blocks the progression of DNA and RNA polymerases. In rapidly dividing tumor cells, these lesions lead to replication fork stall, DNA strand breaks, and the activation of apoptotic signaling pathways (PubMed, 17513805). While highly effective in treating malignancies such as colorectal cancer, the non-specific targeting of DNA in all proliferating cells contributes to systemic toxicities, including neurotoxicity and bone marrow suppression (NIH, NCI Dictionary).

Other names
Genomic DNADeoxyribonucleic acidNuclear genomeChromosomal DNA
02

Mechanism of action

Oxaliplatin undergoes non-enzymatic conversion into active derivatives that covalently bind to the N7 position of guanine and adenine residues in nuclear DNA. This binding forms 1,2-intrastrand crosslinks, 1,3-intrastrand crosslinks, and interstrand crosslinks, which physically impede DNA polymerases and RNA polymerases, triggering cell cycle arrest and inducing apoptosis (StatPearls, NBK542163; PubChem, CID 43805).

03

Biological functions

Genetic information storageDNA replicationTranscriptionCell division
04

Disease associations

Colorectal cancerGastric cancerPancreatic cancerOvarian cancer
05

Safety considerations

Peripheral neuropathy (acute and chronic)Myelosuppression (neutropenia, thrombocytopenia)Hypersensitivity reactionsGastrointestinal toxicity
06

Interacting drugs

Oxaliplatin

4 more in the full profile.

07

Biomarkers

ERCC1 expressionMismatch repair (MMR) statusMicrosatellite instability (MSI)Platinum-DNA adduct levels

Beyond the preview

Go deeper on Nuclear DNA (DNA) (DNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nuclear DNA (DNA) (DNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call